Camptothecin and cisplatin upregulate ABCG2 and MRP2 expression by activating the ATMUNF-κB pathway in lung cancer cells

被引:48
作者
Ke, Shi Zhong [1 ]
Ni, Xiao Yan [1 ]
Zhang, Yue Hua [1 ]
Wang, Yi Nan [1 ]
Wu, Bin [2 ]
Gao, Feng Guang [1 ]
机构
[1] Xiamen Univ, Coll Med, Dept Immunol, Xiamen 361005, Peoples R China
[2] Shanghai Jiao Tong Univ, Affiliated Renji Hosp, Dept Pharmacol, Shanghai 200030, Peoples R China
基金
中国国家自然科学基金;
关键词
ataxia telangietisa mutanted; NF-kappa B; ABCG2; MRP2; lung cancer; INTERSTRAND CROSS-LINKS; MULTIDRUG-RESISTANCE; DNA-DAMAGE; IN-VITRO; ATAXIA-TELANGIECTASIA; DRUG-RESISTANCE; DENDRITIC CELLS; PROTEIN-KINASE; THERAPY; OVEREXPRESSION;
D O I
10.3892/ijo.2013.1805
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Multidrug resistance (MDR) formation is an important problem in lung cancer chemotherapy. Our study showed that both camptothecin and cisplatin could not only induce ATM and NF-kappa B activation but also upregulate expression of the MDR-related genes ABCG2, MRP2 in NCI-H446 cells. Moreover, camptothecin and cisplatin-induced ABCG2 and MRP2 upregulation could be impaired by ATM and NF-kappa B inhibitors, indicating a relationship between ATM, NF-kappa B activation and MDR formation in lung cancer chemotherapy. Our study indicates that ATM may serve as a potential molecular target for MDR formation in lung cancer chemotherapy.
引用
收藏
页码:1289 / 1296
页数:8
相关论文
共 43 条
[21]   Multidrug resistance-associated protein 2 determines the efficacy of cisplatin in patients with hepatocellular carcinoma [J].
Korita, Pavel V. ;
Wakai, Toshifumi ;
Shirai, Yoshio ;
Matsuda, Yasunobu ;
Sakata, Jun ;
Takamura, Masaaki ;
Yano, Masahiko ;
Sanpei, Ayumi ;
Aoyagi, Yutaka ;
Hatakeyama, Katsuyoshi ;
Ajioka, Yoichi .
ONCOLOGY REPORTS, 2010, 23 (04) :965-972
[22]   Targeting transcription factor NF-κB to overcome chemoresistance and radioresistance in cancer therapy [J].
Li, Feng ;
Sethi, Gautam .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2010, 1805 (02) :167-180
[23]   The NF-κB activation pathways, emerging molecular targets for cancer prevention and therapy [J].
Lin, Yong ;
Bai, Lang ;
Chen, Wenjie ;
Xu, Shanling .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (01) :45-55
[24]   KrasG12D-Induced IKK2/β/NF-κB Activation by IL-1α and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal Adenocarcinoma [J].
Ling, Jianhua ;
Kang, Ya'an ;
Zhao, Ruiying ;
Xia, Qianghua ;
Lee, Dung-Fang ;
Chang, Zhe ;
Li, Jin ;
Peng, Bailu ;
Fleming, Jason B. ;
Wang, Huamin ;
Liu, Jinsong ;
Lemischka, Ihor R. ;
Hung, Mien-Chie ;
Chiao, Paul J. .
CANCER CELL, 2012, 21 (01) :105-120
[25]   NF-κB as a target for cancer therapy [J].
Melisi, Davide ;
Chiao, Paul J. .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (02) :133-144
[26]   Nuclear initiated NF-κB signaling: NEMO and ATM take center stage [J].
Miyamoto, Shigeki .
CELL RESEARCH, 2011, 21 (01) :116-130
[27]  
Robey RW, 2001, CLIN CANCER RES, V7, P145
[28]   Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway [J].
Shinoda, C ;
Maruyama, M ;
Fujishita, T ;
Dohkan, J ;
Oda, H ;
Shinoda, K ;
Yamada, T ;
Miyabayashi, K ;
Hayashi, R ;
Kawagishi, Y ;
Fujita, T ;
Matsui, S ;
Sugiyama, E ;
Muraguchi, A ;
Kobayashi, M .
INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (01) :21-31
[29]   Evidence for different mechanisms of 'unhooking' for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samples [J].
Spanswick, Victoria J. ;
Lowe, Helen L. ;
Newton, Claire ;
Bingham, John P. ;
Bagnobianchi, Alessia ;
Kiakos, Konstantinos ;
Craddock, Charles ;
Ledermann, Jonathan A. ;
Hochhauser, Daniel ;
Hartley, John A. .
BMC CANCER, 2012, 12
[30]   Lung cancer: Progress in diagnosis, staging and therapy [J].
Spiro, Stephen G. ;
Tanner, Nichole T. ;
Silvestri, Gerard A. ;
Janes, Sam M. ;
Lim, Eric ;
Vansteenkiste, Johan F. ;
Pirker, Robert .
RESPIROLOGY, 2010, 15 (01) :44-50